Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study

<p>Abstract</p> <p>Background</p> <p>Preoperative capecitabine-based chemoradiation is a standard treatment for locally advanced rectal cancer (LARC). Here, we explored the safety and efficacy of the addition of bevacizumab to capecitabine and concurrent radiotherapy fo...

Full description

Bibliographic Details
Main Authors: Edhemovic Ibrahim, Oblak Irena, Anderluh Franc, Bracko Matej, Music Maja, Ocvirk Janja, Velenik Vaneja, Brecelj Erik, Kropivnik Mateja, Omejc Mirko
Format: Article
Language:English
Published: BMC 2011-08-01
Series:Radiation Oncology
Subjects:
capecitabine
chemoradiation
bevacizumab
locally advanced rectal cancer
LARC
phase II study
Online Access:http://www.ro-journal.com/content/6/1/105

Internet

http://www.ro-journal.com/content/6/1/105

Similar Items